Clinical research suggested doses in the range of 1-10mcg per kilogram of body weight showed efficacy, though most protocols standardized around 4-6mcg/kg for practical application
bu da placebo ile karlatrldnda belirgin bir fark oluturdu
The quiz is not a prescription
Symptoms can include poor feeding, feeling sluggish, and irritability
Moreno-Borque R, Guhl-Milln G, Mera-Carreiro S, Pazos-Guerra M, Corts-Toro JA, Lpez-Bran E
A previous Phase 2 trial in 255 patients with Parkinsons disease suggested pegsebrenatide may slow the progression of motor dysfunction, with the most pronounced effects in patients younger than 60